Nuveen Lifecycle 2030 Retirement (TCLNX)

Nasdaq Currently down 0.01 (-0.06%) in today's trading session

1 member of Congress has disclosed 2 trades in Nuveen Lifecycle 2030 Retirement (TCLNX) via STOCK Act filings. The most recent disclosure was a sale by Julie Fedorchak on 27 August 2025. Aggregate disclosed activity totals roughly $750K in sales (midpoint estimates from bracketed disclosure amounts).

Nuveen Lifecycle 2030 Retirement is currently trading at $17.33, positioned at 80% of its 52-week range ($15.87 – $17.69).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$17.33
24h Change
-0.01 (-0.06%)
52 Week Range
$15.87$17.69
View on NASDAQ

Nuveen Lifecycle 2030 Retirement Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for TCLNX

Select to highlight on chart
2 transactions
Compliance: 0%
Julie Fedorchak27 Aug 202513 Aug 2026SaleStock$250,001 - $500,000N/A
Julie Fedorchak15 Aug 202513 Aug 2026SaleStock$250,001 - $500,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$4.38B

Volume

0

Beta

0.86

P/E Ratio

21.95

Fundamentals

EPS

$0.79

Div. Yield

4.48%

Open

$17.33

Day Range

$17.33 – $17.33

Company Information

Sector
Financial Services
Industry
Asset Management
Exchange
NASDAQ · USD
Country
US
IPO Date
2004-10-06

The Fund seeks high total return over time through a combination of capital appreciation and income by investing in Underlying Funds according to an asset allocation strategy designed for investors planning to retire in or within a few years of 2030.

No earnings data available for this stock.

Dividends

Dividend History

19 Dec 2025
Amount $0.7761
13 Dec 2024
Amount $0.4695
15 Dec 2023
Amount $0.2614
16 Dec 2022
Amount $0.7154
17 Dec 2021
Amount $1.1916
18 Dec 2020
Amount $0.7529
13 Dec 2019
Amount $0.5051
14 Dec 2018
Amount $0.7929
15 Dec 2017
Amount $0.6174
16 Dec 2016
Amount $0.6238
18 Dec 2015
Amount $0.7962
19 Dec 2014
Amount $0.7879
20 Dec 2013
Amount $0.7414
21 Dec 2012
Amount $0.4601
16 Dec 2011
Amount $0.3242
17 Dec 2010
Amount $0.2066
18 Dec 2009
Amount $0.1431
19 Dec 2008
Amount $0.1882
21 Dec 2007
Amount $0.4000
22 Dec 2006
Amount $0.2765
23 Dec 2005
Amount $0.3049
29 Dec 2004
Amount $0.3350

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about TCLNX

Which members of Congress have traded TCLNX?
1 member of Congress has disclosed 2 trade in Nuveen Lifecycle 2030 Retirement (TCLNX) under the STOCK Act: Julie Fedorchak.
When was TCLNX most recently disclosed by Congress?
The most recent TCLNX disclosure was a sale by Julie Fedorchak on 27 August 2025.
What is the total disclosed congressional trading volume for TCLNX?
Members of Congress have disclosed approximately $750K in TCLNX sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in TCLNX?
This TCLNX page updates as soon as new STOCK Act disclosures are filed for Nuveen Lifecycle 2030 Retirement. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.